Logo CICANCER
Intranet Colaborate

Old CIC Events

The role of Polycomb proteins and 3D genome architecture in epigenetic inheritance and cancer 01/07/2024

The role of Polycomb proteins and 3D genome architecture in epigenetic inheritance and cancer

Giacomo Cavalli — Institute of Human Genetics - Université de Montpellier, France

Impact of C3G on hematopoiesis after chemotherapy: effects on hematopoietic precursors and megakaryocyte niche function 27/06/2024

Impact of C3G on hematopoiesis after chemotherapy: effects on hematopoietic precursors and megakaryocyte niche function

Óscar Herranz Varea — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)

Next-generation organoid models for colorectal cancer research 20/06/2024

Next-generation organoid models for colorectal cancer research

L. Francisco Lorenzo-Martín — École Polytechnique Fédérale de Lausanne (EPFL, Lausanne, Switzerland

Tumorigenic potential of the MEK5/ERK5 pathway. 13/06/2024

Tumorigenic potential of the MEK5/ERK5 pathway.

Sofía Matilla Vicente-Almazán — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)

Aberrant fibrotic phenotypes of tumor-associated fibroblasts in lung cancer: translational opportunities 06/06/2024

Aberrant fibrotic phenotypes of tumor-associated fibroblasts in lung cancer: translational opportunities

Jordi Alcaraz — Universitat de Barcelona

Intercellular communication in the immune response: transfer of genetic information during synapsis 30/05/2024

Intercellular communication in the immune response: transfer of genetic information during synapsis

Francisco Sánchez-Madrid — Hospital Universitario de la Princesa. Universidad Autónoma de Madrid. CIBERCV.

Decoding the Extracellular matrix at the immunosuppressive tumor microenvironment: the forgotten partner 22/05/2024

Decoding the Extracellular matrix at the immunosuppressive tumor microenvironment: the forgotten partner

Mª Jose Oliveira — i3S-Institute for Research and Innovation in Health, University of Porto, Portugal

Artificial Intelligence to explore vast chemical spaces for drug leads 16/05/2024

Artificial Intelligence to explore vast chemical spaces for drug leads

Pedro Ballester — Imperial College London

Exploring and exploiting the vasculature in brain tumors 09/05/2024

Exploring and exploiting the vasculature in brain tumors

Leire Bejarano — Ludwig Institute for Cancer Research (LICR), Lausanne, Switzerland

Oncolytic viruses for the treatment of pediatric brain tumors: The force awakens 25/04/2024

Oncolytic viruses for the treatment of pediatric brain tumors: The force awakens

Marta María Alonso Roldán — CIMA, Universidad de Navarra

Cell of origin and molecular drivers of non-small cell lung cancer 18/04/2024

Cell of origin and molecular drivers of non-small cell lung cancer

Rocío Sotillo — German Cancer Research Center (DKFZ), Heidelberg (Germany)

Impact of the hyperactivation of the C3G-Rap1 pathway in murine lymphoma cells 11/04/2024

Impact of the hyperactivation of the C3G-Rap1 pathway in murine lymphoma cells

Alba Morán Vaquero — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)